These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18541474)

  • 41. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells.
    Hutson RG; Kitoh T; Moraga Amador DA; Cosic S; Schuster SM; Kilberg MS
    Am J Physiol; 1997 May; 272(5 Pt 1):C1691-9. PubMed ID: 9176161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
    Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
    Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines.
    Chien WW; Le Beux C; Rachinel N; Julien M; Lacroix CE; Allas S; Sahakian P; Cornut-Thibaut A; Lionnard L; Kucharczak J; Aouacheria A; Abribat T; Salles G
    Sci Rep; 2015 Jan; 5():8068. PubMed ID: 25626693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.
    Akagi T; Yin D; Kawamata N; Bartram CR; Hofmann WK; Song JH; Miller CW; den Boer ML; Koeffler HP
    Leuk Res; 2009 Jul; 33(7):991-6. PubMed ID: 19054556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
    Pastorczak A; Fendler W; Zalewska-Szewczyk B; Górniak P; Lejman M; Trelińska J; Walenciak J; Kowalczyk J; Szczepanski T; Mlynarski W;
    Leuk Res; 2014 Feb; 38(2):180-3. PubMed ID: 24268318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticancer Properties of N,N-dibenzylasparagine as an Asparagine (Asp) analog, Using Colon Cancer Caco-2 Cell Line.
    Mohamed EA; Bassiouny K; Alshambky AA; Khalil H
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2531-2540. PubMed ID: 35901362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical electrostatic interaction mediates inhibitor recognition by human asparagine synthetase.
    Ikeuchi H; Meyer ME; Ding Y; Hiratake J; Richards NG
    Bioorg Med Chem; 2009 Sep; 17(18):6641-50. PubMed ID: 19683931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro.
    Liu WJ; Wang H; Peng XW; Wang WD; Liu NW; Wang Y; Lu Y
    Onco Targets Ther; 2018; 11():6605-6615. PubMed ID: 30349294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
    Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia.
    Chiu M; Taurino G; Bianchi MG; Kilberg MS; Bussolati O
    Front Oncol; 2019; 9():1480. PubMed ID: 31998641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase.
    Ciustea M; Gutierrez JA; Abbatiello SE; Eyler JR; Richards NG
    Arch Biochem Biophys; 2005 Aug; 440(1):18-27. PubMed ID: 16023613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase.
    Bertuccio SN; Serravalle S; Astolfi A; Lonetti A; Indio V; Leszl A; Pession A; Melchionda F
    Oncotarget; 2017 Dec; 8(66):109915-109923. PubMed ID: 29299118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
    Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
    Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
    Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
    Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asparagine synthetase regulates lung-cancer metastasis by stabilizing the β-catenin complex and modulating mitochondrial response.
    Cai DJ; Zhang ZY; Bu Y; Li L; Deng YZ; Sun LQ; Hu CP; Li M
    Cell Death Dis; 2022 Jun; 13(6):566. PubMed ID: 35739087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase.
    Toda K; Kawada K; Iwamoto M; Inamoto S; Sasazuki T; Shirasawa S; Hasegawa S; Sakai Y
    Neoplasia; 2016 Nov; 18(11):654-665. PubMed ID: 27764698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.
    Aslanian AM; Fletcher BS; Kilberg MS
    Biochem J; 2001 Jul; 357(Pt 1):321-8. PubMed ID: 11415466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asparagine synthetase: a new potential biomarker in ovarian cancer.
    Lorenzi PL; Weinstein JN
    Drug News Perspect; 2009; 22(1):61-4. PubMed ID: 19209300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.
    Yu Q; Wang X; Wang L; Zheng J; Wang J; Wang B
    Scand J Gastroenterol; 2016 Oct; 51(10):1220-6. PubMed ID: 27251594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase.
    Gwinn DM; Lee AG; Briones-Martin-Del-Campo M; Conn CS; Simpson DR; Scott AI; Le A; Cowan TM; Ruggero D; Sweet-Cordero EA
    Cancer Cell; 2018 Jan; 33(1):91-107.e6. PubMed ID: 29316436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.